Trials / Completed
CompletedNCT01565681
Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects
A Phase 1 Single Ascending Dose Study of ASKP1240 in Healthy Male and Female Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Astellas Pharma Global Development, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of ASKP1240 after a single intravenous dose at escalating dose levels in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1240 | infusion |
| DRUG | Placebo | infusion |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2012-03-29
- Last updated
- 2012-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01565681. Inclusion in this directory is not an endorsement.